Worldwide, over 3.5 million people suffer from end-stage renal disease. Almost 2.8 million people depend on regular dialysis treatment to prevent damage to other organs through toxin which accumulate in the blood. Fresenius Medical Care is one of the global market leaders in dialysis products and services. Under its brand NephroCare, the company unites 1,080 dialysis centers in over 30 countries, treating more than 93,000 patients. NephroCare France is the brand of the NephroCare service network in France and the market leader nationwide. Managing Director Jean-Marc Cabanel attributes the company’s success to its specialization and technological excellence.